OVERVIEW

Peripheral Drug-eluting Stent System

ZENFLEX® Pro Peripheral Drug-eluting Stent System, the 3rd peripheral drug-eluting stent in the world, is designed especially for complex lesions and restenotic symptomatic lesions.

PRODUCT FEATURES

Peripheral Drug-eluting Stent System

Based on ZENFLEX Peripheral stent platform

UNIQUE STENT DESIGN

Open helical structure

Segmented MicroMesh design

Offset Peak-Valley design

Results in superior flexibility and great radial force of the stent

Promises immediate wall apposition and precise stent placement

Polymer free Coating

The special ZENFLEX® Pro coating technology is a ultrasound spray crystalline paclitaxel.

Uses a special auxiliary gas to recrystallize the drug coating and obtain a stable uniform drug coating layer bonded on the stent surface.

Free from any polymer, adhesive, or excipient, while eliminating the potential risks that polymers may cause.

Provides the effective Paclitaxel tissue concentration within 90 days, and the stent converts into bare stent with complete drug delivery after 180 days

In March 2021, Zylox tonbridge medical technology was once again selected as a technology-based SMEs in Guangdong successfully. So far, TonBridge Medical has been in the list technology-based SMEs in Guangdong for four consecutive years.